Tag: Diffuse midline glioma research

The Brain Tumour Charity has partnered with Worldwide Cancer Research to co-fund research into Diffuse Midline Glioma (DMG), investing £160,000 as part of a joint £400,000 commitment to tackle this devastating childhood brain cancer.

New research shows that stopping the activity of the ACVR1 enzyme could slow tumour growth in diffuse midline gliomas (formerly known as DIPG)

Researchers have found a way to monitor diffuse midline gliomas (formerly known as DIPG) by measuring tumour biomarkers through a blood test

Results from a phase 1 clinical trial of the oncolytic virus DNX-2401, report successful intratumoral delivery of the virus in children with diffuse midline glioma

Recently published research shows that CAR-T cell therapy, a type of immunotherapy, has the ability to treat diffuse midline glioma

Researchers at UC San Francisco develop a vaccine to treat diffuse midline glioma by using the patient’s immune system to attack the tumour cells

A team of researchers from Northwestern University, USA have identified a molecule that could be used to inhibit the growth of the most fatal paediatric brain tumour, diffuse pontine intrinsic glioma (DIPG).

Researchers at the University of Texas Southwestern Medical Center in Dallas have identified a gene called SHOX2 that could be used to better diagnose brain tumours.